2013 News

PharmedOut In the News - 2013

December 2013

  • Dr. Fugh-Berman spoke on "Promoting Profitable Drugs" to the Canadian Agency on Drugs and Technologies in Health (CADTH) in Ottawa. CADTH is an independent, not-for-profit agency that is funded by Canada’s federal, provincial, and territorial governments to provide evidence-based information to health care leaders.
  • December 26: Dr. Fugh-Berman was quoted in Financial Times' article, "Ethics: End of the Hard Sell?", on increased scrutiny of pharmaceutical industry marketing.

November 2013

  • November 24: On the front page of the New York Times's Business Section, Dr. Fugh-Berman was quoted in Natasha Singer's in-depth article on Low-T marketing, "Selling That New-Man Feeling". “There are tests that everyone will fail — that is the idea,” says Dr. Fugh-Berman, who directs PharmedOut, a Georgetown project that educates doctors about drug marketing claims. “'Do you feel tired after dinner?’ Depends how long after dinner. We all do eventually. It’s called sleep."

October 2013

  • October 31: Shannon Brownlee (of the New America Foundation and Lown Institute, author of Overtreated, and regular PharmedOut conference speaker) will lecture on "Is That Really What Your Patient Needs or Wants? The Case for Protecting Patients From Overuse" on Thursday, October 31st, from 1-2:30 p.m. in the New Research Building auditorium at Georgetown. The talk is part of a graduate class, but you are welcome to attend!
  • October 22: Dr. Fugh-Berman was quoted in The Telegraph in "Tired and grumpy? Sounds like it could be a case of Low T" by Nick Allen.
  • October 21: PharmedOut held its second successful seminar on October 21st. Elina Hemminki MD, DrPh, of the University of Helsinki spoke on the "Regulation of Clinical Trials in Finland, Canada, the U.K. and the U.S." Dr. Hemminki spent 10 days with PharmedOut as a Visiting Professor.
  • October 17: We helped Dr. Susan Wood and other colleagues at George Washington University School of Public Health and Health Services with a report to the D.C. Department of Health on the use of antipsychotics among the elderly in Washington, D.C. Findings are summarized in this press release, which links to the full report.

September 2013

  • September 24: Chief Editor of Public Library of Science (PLOS) Medicine cited "The Haunting of Medical Journals: How Ghostwriting Sold 'HRT'" by Dr. Fugh-Berman as one of seven articles PLOS published that made a difference.

Industry Influence Can Be Mediated by Understanding Theory Behind It

Psychiatric News, September 19, 2013

UCLA, Eyeing Profits, Entrusts Tech Transfer to Industry Experts

The Chronicle of Higher Education, August 12, 2013

Pharmaceutical Marketing Abuses: A Conversation With Dr. Adriane Fugh-Berman

The Healthcare Policy Podcast, July 10, 2013

Popular ‘low T’ therapy divides the medical field

USA Today, June 12, 2013

Hot flashes and hormones: A complex issue.

The Washington Post, May 27, 2013

Pills Tracked From Doctor to Patient to Aid Drug Marketing

The New York Times, May 16, 2013

Doctors’ Lucrative Industry Ties

The New York Times, May 13, 2013

Will This Pill Fix Your Sex Life?

The Daily Beast, April 30, 2013

Your Aging Problem: Is It [LowT]? Take this Quiz and Find Out. Or Just Chalk It Up to Clever Marketing. Adriane Fugh-Berman, MD, Explains

Pharma Marketing Blog, April 26, 2013

Should the Modern Man Be Taking Testosterone?

The Atlantic, April 5, 2013

Pharmaceutical industry influence starts with the doctor’s prescribing pen

Association of Health Care Journalists, March 13, 2013

Does Your Doctor Cash in on Drug Company Money?

NBC Washington, March 11, 2013

Urology Group Endorses Live Surgical Events, With Guidelines

Medscape Medical News, April 10, 2013

“The comments in defense of this surgical circus are appalling,” said Adriane Fugh-Berman, MD, who was asked by Medscape Medical News for comment.

Pharma fines increase, but the pain is not felt on Wall Street

Nature Medicine, January 7, 2013